The authors note that semaglutide had a holistic therapeutic approach to both liver disease and associated cardiometabolic illnesses. These results lend further credence that semaglutide is the Swiss army knife of medicine we have been looking for, to treat obesity, cardiovascular disease, type 2 diabetes, and now MASH, Beverly Tchang, MD, an endocrinologist and assistant professor of clinical medicine at Weill Cornell Medicine, not affiliated with the trial, told Healthline.
Its medicine working the way medicine is supposed to work
Weight management is a first-line recommendation in NICE CKS guidance on PCOS and in RCOG resources for this condition
[55] Furthermore, semaglutide actively inhibits pro-inflammatory transcription factors such as NF-B and JNK
See our next webinar: Rethinking the development of controlled release formulations and manufacturing processes Date: 30th of April, Time: 3:00 pm (Amsterdam, Berlin)
The ongoing financial commitment is an important consideration when starting treatment